NextSEQ 2000 Maintenance FY24

The National Institutes of Health - National Institute of Child Health and Human Development intends to procure a Silver Service Support plan from Illumina, Inc. to provide service and maintenance for their NextSeq 2000 sequencer located at their facility. Interested parties must be registered in the System for Award Management and submit pricing by November 13, 2023 to the contact listed. The proposed acquisition will utilize simplified acquisition procedures and incorporate standard FAR clauses for commercial items.

There is no set-aside designated for this procurement. As the NextSeq 2000 sequencer is a highly specialized piece of equipment exclusively sold and serviced by Illumina, this will be a sole source contract justified by both the need for warranty compliance and reliance on the manufacturer for repairs. The service support is required to ensure reliable operation of the sequencer which is used for single cell and exome sequencing to support research on the effects of substances of abuse; maintaining it through the manufacturer's program complies with regulatory standards.